Vectus Biosystems (ASX:VBS) Other Current Liabilities : A$0.59 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Other Current Liabilities?

Vectus Biosystems's other current liabilities for the quarter that ended in Dec. 2023 was A$0.59 Mil.

Vectus Biosystems's quarterly other current liabilities declined from Dec. 2022 (A$0.78 Mil) to Jun. 2023 (A$0.78 Mil) and declined from Jun. 2023 (A$0.78 Mil) to Dec. 2023 (A$0.59 Mil).

Vectus Biosystems's annual other current liabilities increased from Jun. 2021 (A$0.84 Mil) to Jun. 2022 (A$1.30 Mil) but then declined from Jun. 2022 (A$1.30 Mil) to Jun. 2023 (A$0.78 Mil).

Vectus Biosystems Other Current Liabilities Historical Data

The historical data trend for Vectus Biosystems's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Other Current Liabilities Chart

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Current Liabilities

Get a 7-Day Free Trial

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial											-	-	-	-	-

Vectus Biosystems Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Vectus Biosystems Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems (ASX:VBS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018

Website

https://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines